Psychemedics Share Holder Equity 2010-2024 | PMD
Psychemedics share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Psychemedics Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$7 |
| 2022 |
$11 |
| 2021 |
$12 |
| 2020 |
$13 |
| 2019 |
$17 |
| 2018 |
$19 |
| 2017 |
$19 |
| 2016 |
$16 |
| 2015 |
$12 |
| 2014 |
$13 |
| 2013 |
$12 |
| 2012 |
$11 |
| 2011 |
$11 |
| 2010 |
$10 |
| 2009 |
$9 |
Psychemedics Quarterly Share Holder Equity
(Millions of US $) |
| 2024-09-30 |
$5 |
| 2024-06-30 |
$6 |
| 2024-03-31 |
$6 |
| 2023-12-31 |
$7 |
| 2023-09-30 |
$7 |
| 2023-06-30 |
$9 |
| 2023-03-31 |
$10 |
| 2022-12-31 |
$11 |
| 2022-09-30 |
$12 |
| 2022-06-30 |
$12 |
| 2022-03-31 |
$12 |
| 2021-12-31 |
$12 |
| 2021-09-30 |
$14 |
| 2021-06-30 |
$13 |
| 2021-03-31 |
$13 |
| 2020-12-31 |
$13 |
| 2020-09-30 |
$13 |
| 2020-06-30 |
$14 |
| 2020-03-31 |
$16 |
| 2019-12-31 |
$17 |
| 2019-09-30 |
$18 |
| 2019-06-30 |
$18 |
| 2019-03-31 |
$18 |
| 2018-12-31 |
$19 |
| 2018-09-30 |
$19 |
| 2018-06-30 |
$18 |
| 2018-03-31 |
$19 |
| 2017-12-31 |
$19 |
| 2017-09-30 |
$17 |
| 2017-06-30 |
$16 |
| 2017-03-31 |
$16 |
| 2016-12-31 |
$16 |
| 2016-09-30 |
$14 |
| 2016-06-30 |
$12 |
| 2016-03-31 |
$11 |
| 2015-12-31 |
$12 |
| 2015-09-30 |
$12 |
| 2015-06-30 |
$12 |
| 2015-03-31 |
$12 |
| 2014-12-31 |
$13 |
| 2014-09-30 |
$13 |
| 2014-06-30 |
$13 |
| 2014-03-31 |
$12 |
| 2013-12-31 |
$12 |
| 2013-09-30 |
$12 |
| 2013-06-30 |
$12 |
| 2013-03-31 |
$11 |
| 2012-12-31 |
$11 |
| 2012-09-30 |
$12 |
| 2012-06-30 |
$11 |
| 2012-03-31 |
$11 |
| 2011-12-31 |
$11 |
| 2011-09-30 |
$11 |
| 2011-06-30 |
$11 |
| 2011-03-31 |
$10 |
| 2010-12-31 |
$10 |
| 2010-09-30 |
$10 |
| 2010-06-30 |
$10 |
| 2010-03-31 |
$9 |
| 2009-12-31 |
$9 |
| 2009-09-30 |
$9 |
| 2009-06-30 |
$9 |
| 2009-03-31 |
$10 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.014B |
$0.022B |
|
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|
